|
Catalog Number VS-402 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Itching Sensation (1943); Pain (1994); Patient Problem/Medical Problem (2688)
|
Event Date 04/18/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the patient had treatment of the great saphenous vein (gsv) with a venaseal closure system.The ifu was followed during preparation, procedure and post procedure.No tumescent infiltration was used.Local anesthesia was used.The procedure was completed without incident.There was no alleged product issue.Post the procedure, the patient reports an allergic response of discomfort, itching and pain.The physician has prescribed steroids.
|
|
Manufacturer Narrative
|
Additional information: the area treated was the left gsv to the mid-calf.No compression was applied following procedure.Follow-up scan was carried out 3 days post-procedure without any issues identified.Initial reaction was reported as occurring 17 days post the procedure.The patient visited the er for leg swelling and itchiness behind knee.Red streaks were present, and leg described as being warm to touch.Negative for dvt.The physician has prescribed keflex and treated like cellulitis.The treating physician also prescribed benadryl and prednisone taper and pt.Was reported to be better in 5 days.Following resolution of the issue the patient presented at er 11 days later with cellulitis issues again.Patient was prescribed steroid taper again.The patient returned to the treating physician and the patient's calf has been described as swollen and a purple colour.The patient has been referred for a follow-up appointment with another physician.It was reported to the physician that the patient is allergic to ace inhibitors, fluorometholone acetate (steroid eye drops), doxycycline.Sensitivity to tape.Pt had a reaction to betadine, both legs, after the procedure.The patient also mentioned an allergy to prednisone.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the patient is finishing a second course of steroids.It was reported that the patient is status quo.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the patient is reported to be doing well, issue resolved.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|